Risk Factors for Linezolid Resistance in Staphylococcus Aureus
Status: | Completed |
---|---|
Conditions: | Infectious Disease, Hospital |
Therapuetic Areas: | Immunology / Infectious Diseases, Other |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 6/14/2018 |
Start Date: | August 2007 |
End Date: | June 2017 |
This is a retrospective chart review study. The proposed study aims to document the risk
factors for quinolone resistance in bloodstream isolates of Klebsiella species. Additionally,
the adequacy of empiric antibiotic therapy for Klebsiella bloodstream infections will be
assessed.
factors for quinolone resistance in bloodstream isolates of Klebsiella species. Additionally,
the adequacy of empiric antibiotic therapy for Klebsiella bloodstream infections will be
assessed.
This is a retrospective chart review study. The proposed study aims to document the risk
factors for quinolone resistance in bloodstream isolates of Klebsiella species. Additionally,
the adequacy of empiric antibiotic therapy for Klebsiella bloodstream infections will be
assessed. This research is important because identification of risk factors may allow earlier
initiation of appropriate therapy in patients infected with these bacteria. Additionally, we
will identify whether horizontal spread is responsible for this increasing trend.
factors for quinolone resistance in bloodstream isolates of Klebsiella species. Additionally,
the adequacy of empiric antibiotic therapy for Klebsiella bloodstream infections will be
assessed. This research is important because identification of risk factors may allow earlier
initiation of appropriate therapy in patients infected with these bacteria. Additionally, we
will identify whether horizontal spread is responsible for this increasing trend.
Inclusion Criteria:
- patients with linezolid resistance to staphylococcus aureus
Exclusion Criteria:
- those that don't meet entry criteria
We found this trial at
1
site
University of Pittsburgh Medical Center UPMC is one of the leading nonprofit health systems in...
Click here to add this to my saved trials
